No retraction, correction or concern found when last checked on Nov 2, 2026.

SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB

Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese and 19 more

Communications Biology · 2022 · CC BY

doi:10.1101/2020.07.21.212639

Abstract

SARS-CoV-2 is a novel virus that has rapidly spread, causing a global pandemic. In the majority of infected patients, SARS-CoV-2 leads to mild disease; however, in a significant proportion of infections, individuals develop severe symptoms that can lead to long-lasting lung damage or death. These severe cases are often associated with high levels of pro-inflammatory cytokines and low antiviral responses, which can cause systemic complications. Here, we have evaluated transcriptional and cytokine secretion profiles and detected a distinct upregulation of inflammatory cytokines in infected cell cultures and samples taken from infected patients. Building on these observations, we found a specific activation of NF-κB and a block of IRF3 nuclear translocation in SARS-CoV-2 infected cells. This NF-κB response was mediated by cGAS-STING activation and could be attenuated through several STING-targeting drugs. Our results show that SARS-CoV-2 directs a cGAS-STING mediated, NF-κB-driven inflammatory immune response in human epithelial cells that likely contributes to inflammatory responses seen in patients and could be therapeutically targeted to suppress severe disease symptoms.

References 88

1.
Polak, S. B., Van Gool, I. C., Cohen, D., von der Thusen, J. H. & van Paassen, J. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod. Pathol.33, 2128–2138 (2020).
Not in our library10.1038/s41379-020-0603-3
2.
Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
Not in our library10.1016/s0140-6736(20)30183-5
3.
Mehta P, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033-1034.
Not in our library10.1016/s0140-6736(20)30628-0
4.
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing · 2020
Corrected
5.
Chua, R. L. et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat. Biotechnol.38, 970–979 (2020).
Not in our library10.1038/s41587-020-0602-4
6.
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients · 2020
No notice
7.
Rehwinkel, J. & Gack, M. U. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol.20, 537–551 (2020).
Not in our library10.1038/s41577-020-0288-3
8.
Hopfner, K. P. & Hornung, V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat. Rev. Mol. Cell Biol.21, 501–521 (2020).
Not in our library10.1038/s41580-020-0244-x
9.
Ma Z, Damania B. The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe. 2016;19:150-158.
Not in our library10.1016/j.chom.2016.01.010
10.
Schoggins JW, et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature. 2014;505:691-695.
Not in our library10.1038/nature12862
11.
Goubau D, Deddouche S, Reis e Sousa C. Cytosolic sensing of viruses. Immunity. 2013;38:855-869.
Not in our library10.1016/j.immuni.2013.05.007
12.
Blanco-Melo D, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036-1045 e1039.
Not in our library10.1016/j.cell.2020.04.026
13.
Vanderheiden, A. et al. Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J. Virol. 94, e00985 (2020).
Not in our library10.1128/jvi.00985-20
14.
Stanifer, M. L. et al. Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells. Cell Rep. 32, 107863 (2020).
Not in our library10.1016/j.celrep.2020.107863
15.
Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy · 2021
No notice
16.
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells · 2021
No notice
17.
Rebendenne, A. et al. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J. Virol. 95, e02415-20 (2021).
Not in our library10.1128/jvi.02415-20
18.
The RNA sensor MDA5 detects SARS-CoV-2 infection · 2021
No notice
19.
Interplay between SARS-CoV-2 and the type I interferon response · 2020
No notice
20.
Kreimendahl, S. & Rassow, J. The mitochondrial outer membrane protein Tom70-Mediator in protein traffic, membrane contact sites and innate immunity. Int. J. Mol. Sci.21, 7262 (2020).
Not in our library10.3390/ijms21197262
21.
Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature583, 459–468 (2020).
Not in our library10.1038/s41586-020-2286-9
22.
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70 · 2020
No notice
23.
Shi CS, et al. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J. Immunol. 2014;193:3080-3089.
Not in our library10.4049/jimmunol.1303196
24.
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response · 2020
No notice
25.
Evasion of Type I Interferon by SARS-CoV-2 · 2020
No notice
26.
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling · 2020
No notice
27.
Chen DY, et al. SARS-CoV-2 disrupts proximal elements in the JAK-STAT Pathway. J Virol. 2021;95:e0086221.
Not in our library10.1128/jvi.00862-21
28.
Cortese M, et al. Integrative imaging reveals SARS-CoV-2-induced reshaping of subcellular morphologies. Cell Host Microbe. 2020;28:853-866 e855.
Not in our library10.1016/j.chom.2020.11.003
29.
Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA. 2005;102:15545-15550.
Not in our library10.1073/pnas.0506580102
30.
Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage · 2018
No notice
31.
Xie XH, et al. Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway. Pediatr. Res. 2009;65:156-162.
Not in our library10.1203/pdr.0b013e318191f5c6
32.
Chow AW, et al. Polarized secretion of interleukin (IL)-6 and IL-8 by human airway epithelia 16HBE14o- cells in response to cationic polypeptide challenge. PLoS ONE. 2010;5:e12091.
Not in our library10.1371/journal.pone.0012091
33.
Schmid B, et al. Live cell analysis and mathematical modeling identify determinants of attenuation of dengue virus 2’-O-methylation mutant. PLoS. Pathog. 2015;11:e1005345.
Not in our library10.1371/journal.ppat.1005345
34.
Hoagland DA, et al. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity. 2021;54:557-570 e555.
Not in our library10.1016/j.immuni.2021.01.017
35.
Clark K, et al. Novel cross-talk within the IKK family controls innate immunity. Biochem J. 2011;434:93-104.
Not in our library10.1042/bj20101701
36.
Falvo JV, Tsytsykova AV, Goldfeld AE. Transcriptional control of the TNF gene. Curr. Dir. Autoimmun. 2010;11:27-60.
Not in our library10.1159/000289196
37.
Trede NS, Tsytsykova AV, Chatila T, Goldfeld AE, Geha RS. Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: role of NF-kappa B. J. Immunol. 1995;155:902-908.
Not in our library
38.
NF-κB signaling in inflammation · 2017
No notice
39.
Aguirre S, et al. Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection. Nat. Microbiol. 2017;2:17037.
Not in our library10.1038/nmicrobiol.2017.37
40.
Dengue virus activates cGAS through the release of mitochondrial DNA · 2017
No notice
41.
cGAS and STING: At the intersection of DNA and RNA virus-sensing networks · 2018
No notice
42.
Franz KM, Neidermyer WJ, Tan YJ, Whelan SPJ, Kagan JC. STING-dependent translation inhibition restricts RNA virus replication. Proc. Natl Acad. Sci. USA. 2018;115:E2058-E2067.
Not in our library10.1073/pnas.1716937115
43.
Ablasser A, et al. cGAS produces a 2’-5’-linked cyclic dinucleotide second messenger that activates STING. Nature. 2013;498:380-384.
Not in our library10.1038/nature12306
44.
Gao P, et al. Cyclic [G(2’,5’)pA(3’,5’)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell. 2013;153:1094-1107.
Not in our library10.1016/j.cell.2013.04.046
45.
Diner EJ, et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 2013;3:1355-1361.
Not in our library10.1016/j.celrep.2013.05.009
46.
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS · 2020
No notice
47.
Maekawa H, et al. Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury. Cell Rep. 2019;29:1261-1273 e1266.
Not in our library10.1016/j.celrep.2019.09.050
48.
Stempel, M. et al. The herpesviral antagonist m152 reveals differential activation of STING-dependent IRF and NF-kappaB signaling and STING’s dual role during MCMV infection. EMBO J.38, e100983 (2019).
Not in our library10.15252/embj.2018100983
49.
de Oliveira Mann CC, et al. Modular architecture of the STING C-terminal tail allows interferon and NF-kappaB signaling adaptation. Cell Rep. 2019;27:1165-1175 e1165.
Not in our library10.1016/j.celrep.2019.03.098
50.
Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461:788-792.
Not in our library10.1038/nature08476
51.
Haag SM, et al. Targeting STING with covalent small-molecule inhibitors. Nature. 2018;559:269-273.
Not in our library10.1038/s41586-018-0287-8
52.
Chu H, et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19. Clin. Infect. Dis. 2020;71:1400-1409.
Not in our library10.1093/cid/ciaa410
53.
Karki, R. et al. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell184, 149–168 (2020).
Not in our library10.1016/j.cell.2020.11.025
54.
Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodriguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62-75.
Not in our library10.1016/j.cytogfr.2020.06.001
55.
Taniguchi K, Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age. Nat. Rev. Immunol. 2018;18:309-324.
Not in our library10.1038/nri.2017.142
56.
NF-kappaB: Two Sides of the Same Coin · 2018
No notice
57.
Hariharan, A., Hakeem, A. R., Radhakrishnan, S., Reddy, M. S. & Rela, M. The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients. Inflammopharmacology29, 91–100 (2020).
Not in our library10.1007/s10787-020-00773-9
58.
Pahmeier, F. et al. A versatile reporter system to monitor virus infected cells and its application to dengue virus and SARS-CoV-2. J. Virol.95, e01715-20 (2020).
Not in our library10.1128/jvi.01715-20
59.
Ting AT, Bertrand MJM. More to life than NF-kappaB in TNFR1 signaling. Trends Immunol. 2016;37:535-545.
Not in our library10.1016/j.it.2016.06.002
60.
Santoro MG, Rossi A, Amici C. NF-kappaB and virus infection: who controls whom. Embo J. 2003;22:2552-2560.
Not in our library10.1093/emboj/cdg267
61.
Goodwin, C. M., Ciesla, J. H. & Munger, J. Who’s driving? Human cytomegalovirus, interferon, and NFkappaB signaling. Viruses10, 447 (2018).
Not in our library10.3390/v10090447
62.
Struzik J, Szulc-Dabrowska L. Manipulation of non-canonical NF-kappaB signaling by non-oncogenic viruses. Arch. Immunol. Ther. Exp. 2019;67:41-48.
Not in our library10.1007/s00005-018-0522-x
63.
Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011;21:103-115.
Not in our library10.1038/cr.2010.178
64.
The Crosstalk of Endoplasmic Reticulum (ER) Stress Pathways with NF-κB: Complex Mechanisms Relevant for Cancer, Inflammation and Infection · 2018
No notice
65.
Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune Response through Disruption of STING-Mediated Signaling · 2012
No notice
66.
Clementz MA, et al. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 2010;84:4619-4629.
Not in our library10.1128/jvi.02406-09
67.
SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex · 2014
No notice
68.
Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins · 2021
No notice
69.
Ghosh S, et al. beta-Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway. Cell. 2020;183:1520-1535 e1514.
Not in our library10.1016/j.cell.2020.10.039
70.
Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013;155:688-698.
Not in our library10.1016/j.cell.2013.09.049
71.
Hotamisligil, G. S. & Davis, R. J. Cell signaling and stress responses. Cold Spring Harb. Perspect. Biol. 8, a006072 (2016).
Not in our library10.1101/cshperspect.a006072
72.
Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J. Autoimmun. 2020;111:102452.
Not in our library10.1016/j.jaut.2020.102452
73.
Atal, S. & Fatima, Z. IL-6 inhibitors in the treatment of serious COVID-19: a promising therapy? Pharmaceut. Med. 34, 223–231 (2020).
Not in our library10.1007/s40290-020-00342-z
74.
Theoharides, T. C. & Conti, P. Dexamethasone for COVID-19? Not so fast. J. Biol. Regul. Homeost. Agents34, 1241–1243 (2020).
Not in our library10.23812/20-editorial_1-5
75.
Kolilekas, L. et al. Can steroids reverse the severe COVID-19 induced “cytokine storm”? J. Med. Virol.92, 2866–2869 (2020).
Not in our library10.1002/jmv.26165
76.
Fadel, R. et al. Early short course corticosteroids in hospitalized patients with COVID-19. Clin. Infect. Dis.71, 2114–2120 (2020).
Not in our library10.1093/cid/ciaa601
77.
DeDiego ML, et al. Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J. Virol. 2014;88:913-924.
Not in our library10.1128/jvi.02576-13
78.
Neufeldt, C. J. et al. ER-shaping atlastin proteins act as central hubs to promote flavivirus replication and virion assembly. Nat. Microbiol. 4, 2416–2429 (2019).
Not in our library10.1038/s41564-019-0586-3
79.
limma powers differential expression analyses for RNA-sequencing and microarray studies · 2015
No notice
80.
Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics. 2007;23:3251-3253.
Not in our library10.1093/bioinformatics/btm369
81.
Korotkevich, G. et al. Fast gene set enrichment analysis. bioRxiv, 060012 (2021).
Not in our library
82.
Liberzon A, et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417-425.
Not in our library10.1016/j.cels.2015.12.004
83.
MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer · 2019
No notice
84.
CellProfiler Analyst: data exploration and analysis software for complex image-based screens · 2008
No notice
85.
Prasad V, et al. The UPR sensor IRE1alpha and the adenovirus E3-19K glycoprotein sustain persistent and lytic infections. Nat. Commun. 2020;11:1997.
Not in our library10.1038/s41467-020-15844-2
86.
REAP: A two minute cell fractionation method · 2010
No notice
87.
Halama N, et al. Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin. Cancer Res. 2011;17:678-689.
Not in our library10.1158/1078-0432.ccr-10-2173
88.
Neufeldt, C. et al. NCBI Gene expression Omnibus. Micro-array analysis of SARS-CoV2 treated Calu3 and A549-ACE2 cells. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189086 (2021).
Not in our library

Cited by papers we hold 6

The cGAS–STING pathway drives type I IFN immunopathology in COVID-19 · 2022
No notice
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells? · 2021
No notice
SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation · 2021
No notice
Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2 · 2021
No notice
The RNA sensor MDA5 detects SARS-CoV-2 infection · 2021
No notice
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients · 2020
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.